PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 9:49 AM ET

Sponsor Check › Person

MS
No photo found yet (own website and image search run after this page is viewed)

Matthew Strobeck

Named as an officer, director or promoter on SEC Form D filings · CO, VT, AZ · Mar 25, 2014 → Jun 29, 2026

7deals (issuers)
$116.9Mreported sold
138investors
48Form D filings
2014–2026years on file
Follow this personLook further ↓PDF

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:30 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Matthew Strobeck is listed as an executive officer, director, and promoter on 48 SEC Form D filings by 7 issuers between Jul 2012 and Jun 2026. Largest by amount reported sold: Birchview Fund LLC (Burlington, VT — pooled investment fund — 2014–2026; $55.8M reported sold to 53 investors), Accelerate Diagnostics, Inc (Tucson, AZ — biotechnology — 2012–2022; $32M reported sold to 8 investors), BIODESIX INC (Boulder, CO — biotechnology — 2012–2020; $17.8M reported sold to 33 investors), Monteris BC Holdings 3, LLC (Burlington, VT — investing — 2018–2020; $6.55M reported sold to 18 investors), Monteris BC Holdings 2, LLC (Burlington, VT — investing — 2017–2020; $4.29M reported sold to 19 investors) and 2 more (all listed below).

What this means A repeat sponsor — 7 separate companies raised money with this person listed as executive officer, director, and promoter, over about 14 years. Across those companies the filings report $116.9M sold in total.

Listed alongside Jack Schuler (33 shared filings), John Patience (26 shared filings), Mark Miller (25 shared filings), David Brunel (20 shared filings), Robert Cawthorn (20 shared filings) and 31 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Matthew. Each name links to their own page.

5 of the issuers belong to the sponsor group Monteris (14 issuers, $162.9M reported sold, 2014–2026).

What this means A sponsor group is one team that sets up a new company for each deal. Monteris has 14 companies on file and $162.9M reported sold in total — the group page shows the whole track record in one place.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CO, CT, DC, DE, FINRA, FL, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VT, WA, WI, WV, WY) — none found.

What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.

We compared 48 public filings for Matthew Strobeck and found 20 differences, 6 worth asking the sponsor about: Regulator action naming a team member: Jack W. Schuler (Sep 25, 2024); Regulator action naming a team member: Acceler8 Technology Corporation, Thomas V. Geimer, Harry J. Fleury, and James Godkin (Jul 19, 2001); and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Matthew Strobeck has not run yet — it is joining a line of 41,494 names; searches run around the clock at the hosts' allowed rate. Searched so far: 641 names.

Community comments are quoted as written by their authors. Sources searched: Bing (site:reddit.com / site:biggerpockets.com) and Reddit's own search, plus DuckDuckGo/Brave/BiggerPockets search when they are answering.

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:30 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: 48 regulators (FINRA, NASAA, 37 states) — crawled Oct 24, 2026, 8:48 AM ET

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Matthew Strobeck..

State securities regulators: Securities regulators searched (64,910 actions): FINRA (38,350 actions, 1995–2026), NASAA (31 actions, 2000–2026; listing starts 1997), AK Division of Banking and Securities (273 actions, 1971–2025), AL Securities Commission (880 actions, 2001–2026), AR Securities Department (1,305 actions, 1998–2026), AZ Corporation Commission Securities Division (411 actions, 2017–2026), CA DFPI (25 actions, 2007–2024; listing starts 2002 — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), CO Division of Securities (731 actions, 2001–2026; older years from the Internet Archive (snapshot of 2026-05-02)), CT Department of Banking Securities Division (940 actions, 2006–2026; older years from the Internet Archive (snapshot of 2026-04-22)), DC DISB Securities Bureau (25 actions, 2012–2026), DE DOJ Investor Protection Unit (257 actions, 1987–2026), FL Office of Financial Regulation (49 actions, 2018–2026), GA Secretary of State Securities Division (65 actions, 2015–2026; listing starts 2012), HI DCCA Securities Enforcement Branch (26 actions, 2012–2026), ID Department of Finance Securities Bureau (663 actions, 1994–2026), IL Secretary of State Securities Department (4,122 actions, 2003–2023), KS Insurance Department Securities Division (58 actions), KY Department of Financial Institutions (342 actions, 2005–2026), LA Office of Financial Institutions Securities Division (13 actions, 2010–2025; listing starts 2008), MA Secretary of the Commonwealth Securities Division (125 actions, 2012–2025; live site blocks automated access — loaded from the Internet Archive snapshot of 2026-02-04), MD Attorney General Securities Division (1,054 actions, 2004–2026), ME Office of Securities (539 actions, 2000–2026), MI LARA Corporations, Securities & Commercial Licensing Bureau (201 actions), MO Secretary of State Securities Division (919 actions, 1998–2026), MS Secretary of State Securities Division (209 actions, 1995–2026), MT Commissioner of Securities and Insurance (597 actions, 2000–2026), NC Secretary of State Securities Division (265 actions, 2004–2024), ND Securities Department (711 actions, 1990–2026; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2026-01-06), NH Bureau of Securities Regulation (402 actions, 2002–2026), NM Regulation and Licensing Department Securities Division (90 actions, 2010–2025), NV Secretary of State Securities Division (118 actions, 2018–2026), NY Attorney General Investor Protection Bureau (44 actions, 2012–2026), OH Division of Securities (327 actions, 1993–2006), OK Department of Securities (2,531 actions, 1998–2026), OR Division of Financial Regulation (589 actions, 1988–2026), PA Department of Banking and Securities (1,448 actions, 2008–2024; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2024-08-09), RI DBR Securities Division (98 actions, 2005–2025), SC Attorney General Securities Division (540 actions, 2006–2026), SD Division of Insurance – Securities Regulation (106 actions, 2017–2026), TN Department of Commerce and Insurance Securities Division (405 actions, 1992–2026), TX State Securities Board (936 actions, 1999–2026), UT Division of Securities (772 actions, 2000–2026; older years from the Internet Archive (snapshot of 2010-05-27)), VT DFR Securities Division (137 actions, 2010–2026), WA DFI (2,039 actions, 2001–2026), WI DFI Division of Securities (1,072 actions, 1998–2026), WV Securities Commission (State Auditor) (64 actions), WY Secretary of State Compliance Division (6 actions, 2016–2024) — last crawled Oct 24, 2026, 8:48 AM ET. No machine-readable public listing today for IA, IN, MN, NE, NJ, VA (see docs/state-regulators.md).

3. Bankruptcies

None found in sources searched — federal bankruptcy courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:30 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

20 differences found between the filings for Matthew Strobeck — 6 worth asking about (compared 48 filings on Oct 24, 2026)

Worth asking · Sep 25, 2024

Regulator action naming a team member: Jack W. Schuler (Sep 25, 2024)

A ap release dated Sep 25, 2024 names Jack Schuler (listed on the same filings). The release is the source; we do not summarize its outcome here.

What this means A regulator filed or announced an action naming this person or company (or someone on the same filings). Read the release; ask the sponsor what it was and how it ended.

Jack W. Schuler ↗Jack Schuler — PartnerFacts page ↗
Sources
Worth asking · Jul 19, 2001

Regulator action naming a team member: Acceler8 Technology Corporation, Thomas V. Geimer, Harry J. Fleury, and James Godkin (Jul 19, 2001)

An SEC litigation release dated Jul 19, 2001 names Thomas V. Geimer (listed on the same filings). Our match estimate: 80%. The release is the source; we do not summarize its outcome here.

What this means A regulator filed or announced an action naming this person or company (or someone on the same filings). Read the release; ask the sponsor what it was and how it ended.

Acceler8 Technology Corporation, Thomas V. Geimer, Harry J. Fleury, and James Godkin ↗Thomas V. Geimer — PartnerFacts page ↗
Sources
Worth asking · Mar 1, 2021 – Sep 29, 2021

Amount sold went down between filings — Accelerate Diagnostics, Inc

The Mar 1, 2021 filing says $32,000,000 sold; the Sep 29, 2021 Form D/A says $1,550,000 sold — $30,450,000 less.

What this means Amounts sold normally only go up as a raise continues. A drop can mean investors were refunded, a figure was corrected, or an earlier number was wrong. Ask the sponsor which it was.

Form D (earlier) · Mar 1, 2021 ↗Form D/A (later) · Sep 29, 2021 ↗Accelerate Diagnostics, Inc — PartnerFacts page ↗
Sources
Worth asking · Mar 1, 2021 – Sep 29, 2021

Investor count went down between filings — Accelerate Diagnostics, Inc

The Mar 1, 2021 filing reports 8 investors; the Sep 29, 2021 Form D/A reports 5 investors.

What this means Investor counts normally only grow. A smaller number can mean investors left or were refunded, or a count was corrected. Ask the sponsor what happened.

Form D (earlier) · Mar 1, 2021 ↗Form D/A (later) · Sep 29, 2021 ↗Accelerate Diagnostics, Inc — PartnerFacts page ↗
Sources
Worth asking · May 31, 2017 – Jun 13, 2017

Investor count went down between filings — Monteris BC Holdings 2, LLC

The May 31, 2017 filing reports 19 investors; the Jun 13, 2017 Form D/A reports 17 investors.

What this means Investor counts normally only grow. A smaller number can mean investors left or were refunded, or a count was corrected. Ask the sponsor what happened.

Form D (earlier) · May 31, 2017 ↗Form D/A (later) · Jun 13, 2017 ↗Monteris BC Holdings 2, LLC — PartnerFacts page ↗
Sources
Note · Jan 22, 2026

11% of the money raised went to insiders — Birchview Fund LLC

The Jan 22, 2026 Form D/A reports $55,760,701 sold and $6,159,354 of the proceeds used for payments to officers, directors or promoters (marked as an estimate). Issuer's note: "The Investment Manager will receive a management fee based on the issuer's net assets and the Manager may receive an incentive allocation based on the increase in the issuer's net assets.".

What this means The filing reports how much of the money raised was paid to insiders. Over 10% is high for most deals. Ask what it paid for.

Form D/A · Jan 22, 2026 ↗Birchview Fund LLC — PartnerFacts page ↗
Sources
Note · Jan 22, 2025

11% of the money raised went to insiders — Birchview Fund LLC

The Jan 22, 2025 Form D/A reports $50,301,360 sold and $5,472,967 of the proceeds used for payments to officers, directors or promoters (marked as an estimate). Issuer's note: "The Investment Manager will receive a management fee based on the issuer's net assets and the Manager may receive an incentive allocation based on the increase in the issuer's net assets.".

What this means The filing reports how much of the money raised was paid to insiders. Over 10% is high for most deals. Ask what it paid for.

Form D/A · Jan 22, 2025 ↗Birchview Fund LLC — PartnerFacts page ↗
Sources
Note · Jan 22, 2024

10% of the money raised went to insiders — Birchview Fund LLC

The Jan 22, 2024 Form D/A reports $48,951,360 sold and $4,901,594 of the proceeds used for payments to officers, directors or promoters (marked as an estimate). Issuer's note: "The Investment Manager will receive a management fee based on the issuer's net assets and the Manager may receive an incentive allocation based on the increase in the issuer's net assets.".

What this means The filing reports how much of the money raised was paid to insiders. Over 10% is high for most deals. Ask what it paid for.

Form D/A · Jan 22, 2024 ↗Birchview Fund LLC — PartnerFacts page ↗
Sources
Worth asking · Jun 26, 2012 – Mar 1, 2021

8 Form Ds were filed more than 15 days after the first sale

Form D filed 67 days after the first sale — Accelerate Diagnostics, Inc · Form D filed 356 days after the first sale — Birchview Fund LLC · Form D filed 40 days after the first sale — Monteris BC Holdings 3, LLC · Form D filed 16 days after the first sale — BIODESIX INC · Form D filed 25 days after the first sale — BIODESIX INC · and 3 more

What this means Late notices are common and carry no penalty by themselves. A pattern of late paperwork is worth asking the sponsor about.

Form D · Mar 1, 2021 ↗Accelerate Diagnostics, Inc — PartnerFacts page ↗Form D · Mar 11, 2015 ↗Birchview Fund LLC — PartnerFacts page ↗
Sources
Note · Aug 21, 2012 – Oct 2, 2020

16 offerings have no amendment in the last 12 months and may still be open

No amendment in the last 12 months on an offering that may still be open — Monteris BC Holdings 3, LLC (latest filing Oct 2, 2020) · No amendment in the last 12 months on an offering that may still be open — BIODESIX INC (latest filing Oct 1, 2020) · No amendment in the last 12 months on an offering that may still be open — BIODESIX INC (latest filing Aug 22, 2019) · No amendment in the last 12 months on an offering that may still be open — BIODESIX INC (latest filing Oct 23, 2018) · No amendment in the last 12 months on an offering that may still be open — BIODESIX INC (latest filing May 8, 2018) · and 11 more

What this means SEC rules expect a yearly amendment while an offering is still going. Ask the sponsor which of these raises have closed.

Form D/A · Oct 2, 2020 ↗Monteris BC Holdings 3, LLC — PartnerFacts page ↗Form D/A · Oct 1, 2020 ↗BIODESIX INC — PartnerFacts page ↗
Sources
Note · Dec 3, 2013 – Sep 29, 2021

4 offerings changed their target amount between filings

Offering amount lowered between filings — Accelerate Diagnostics, Inc · Offering amount changed between filings — BIODESIX INC · Offering amount lowered between filings — Monteris BC Holdings 2, LLC · Offering amount changed between filings — BIODESIX INC

What this means Targets change as deals grow or shrink. Ask whether later money has the same terms.

Form D (earlier) · Mar 1, 2021 ↗Form D/A (later) · Sep 29, 2021 ↗Accelerate Diagnostics, Inc — PartnerFacts page ↗Form D (earlier) · Dec 20, 2019 ↗
Sources
Note · Jan 11, 2019 – Jan 22, 2020

Minimum investment changed between filings — Birchview Fund LLC

The Jan 11, 2019 filing lists a minimum of $1,000,000; the Jan 22, 2020 Form D/A lists $100,000.

What this means A different minimum usually means the offering terms changed. Check which terms apply to you.

Form D/A (earlier) · Jan 11, 2019 ↗Form D/A (later) · Jan 22, 2020 ↗Birchview Fund LLC — PartnerFacts page ↗
Sources
Note · May 31, 2017 – Jun 13, 2017

Minimum investment changed between filings — Monteris BC Holdings 2, LLC

The May 31, 2017 filing lists a minimum of $50,000; the Jun 13, 2017 Form D/A lists $10,000.

What this means A different minimum usually means the offering terms changed. Check which terms apply to you.

Form D (earlier) · May 31, 2017 ↗Form D/A (later) · Jun 13, 2017 ↗Monteris BC Holdings 2, LLC — PartnerFacts page ↗
Sources
Note · Jul 17, 2012 – Aug 28, 2019

Matthew Strobeck is written 2 different ways on the filings

listed as "Matthew Strobeck" on 43 filings (from Jul 17, 2012), and "Matthew W. Strobeck" on 5 filings (from Aug 28, 2019).

What this means Same person, written differently — a middle name or suffix left off, or spelled another way. It is normal, but check that the full legal name matches your subscription documents.

Form D · Jul 17, 2012 ↗Form D · Aug 28, 2019 ↗Matthew Strobeck — PartnerFacts page ↗
Sources
Note · Jul 17, 2012 – Mar 1, 2021

Reported revenue range changed between filings — Accelerate Diagnostics, Inc

"$1,000,001 - $5,000,000" (Jul 17, 2012); then "Decline to Disclose" (Aug 28, 2019); then "$5,000,001 - $25,000,000" (Mar 1, 2021).

What this means This is the size band the issuer picks for itself on the form. A change can mean the business grew or shrank — or that it chose not to say. Ask for current numbers.

Form D · Jul 17, 2012 ↗Form D · Aug 28, 2019 ↗Form D · Mar 1, 2021 ↗Accelerate Diagnostics, Inc — PartnerFacts page ↗
Sources
Note · Nov 21, 2016 – Sep 15, 2022

Same name, different state: "Matthew Strobeck" (MN) is a separate record

This page covers filings where the address state is CO or VT or AZ. A separate record, "Matthew Strobeck" with address state MN, is listed on 7 filings — most recently by Monteris Medical US, Inc. (Sep 15, 2022). Both records have filings in the same period (Nov 21, 2016 to Sep 15, 2022).

What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.

Matthew Strobeck (MN) — PartnerFacts page ↗Form D · Sep 15, 2022 ↗Monteris Medical US, Inc. — PartnerFacts page ↗Matthew Strobeck (CO,VT,AZ) — this page ↗
Sources
Note · Sep 8, 2014

Same name, different state: "Matthew Strobeck" (MA) is a separate record

This page covers filings where the address state is CO or VT or AZ. A separate record, "Matthew Strobeck" with address state MA, is listed on 1 filing — most recently by YIELD10 BIOSCIENCE, INC. (Sep 8, 2014). Both records have filings in the same period (Sep 8, 2014).

What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.

Matthew Strobeck (MA) — PartnerFacts page ↗Form D · Sep 8, 2014 ↗YIELD10 BIOSCIENCE, INC. — PartnerFacts page ↗Matthew Strobeck (CO,VT,AZ) — this page ↗
Sources
Note · Mar 8, 2010 – Nov 24, 2010

Same name, different state: "Matthew Strobeck" (RI) is a separate record

This page covers filings where the address state is CO or VT or AZ. A separate record, "Matthew Strobeck" with address state RI, is listed on 2 filings — most recently by Precision Dermatology, Inc. (Nov 24, 2010). The two records do not overlap in time: this page runs Mar 25, 2014 to Jun 29, 2026; the other runs Mar 8, 2010 to Nov 24, 2010.

What this means Could be the same person who moved, or two people with the same name. We keep them apart until a filing ties them together. Check both pages before you decide.

Matthew Strobeck (RI) — PartnerFacts page ↗Form D · Nov 24, 2010 ↗Precision Dermatology, Inc. — PartnerFacts page ↗Matthew Strobeck (CO,VT,AZ) — this page ↗
Sources
Note · Jul 17, 2012 – Aug 28, 2019

Address moved from Denver, CO to Tucson, AZ — Accelerate Diagnostics, Inc

The people listed on the Jul 17, 2012 filing give Denver, CO; on the Aug 28, 2019 filing they give Tucson, AZ.

What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.

Form D · Jul 17, 2012 ↗Form D · Aug 28, 2019 ↗Accelerate Diagnostics, Inc — PartnerFacts page ↗
Sources
Note · Jul 17, 2012 – Jun 29, 2026

Matthew Strobeck is listed with 3 different address states: CO, VT, AZ

CO on 21 filings (Jul 17, 2012 to Oct 1, 2020); VT on 22 filings (Mar 25, 2014 to Jun 29, 2026); AZ on 5 filings (Aug 28, 2019 to Apr 7, 2022).

What this means The address on a Form D is usually the company's, not the person's home, so this often just reflects different companies. It can also mean a move. Nothing wrong by itself.

Form D · Jul 17, 2012 ↗Form D · Mar 25, 2014 ↗Form D · Aug 28, 2019 ↗
Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

1 of 28 offerings reports sales commissions totalling $40,813; 0 report finder's fees; 1 reports proceeds to related persons totalling $6,159,354. (includes amounts the issuer reported as estimates)

Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Jun 29, 2026 D
Birchview SB-68 Healthcare Fund LLC
File 021-588868
$0 (est.)$0 (est.)$0 (est.)
Birchview SB-68 Healthcare Partners, LLC, Birchview Capital, LP, and certain persons listed in Item 3 may receive a management fee based on the value of the issuer's assets and/or a performance-based fee based on the issuer's profits.
None listed on this filingEDGAR ↗
Jan 22, 2026 D/A
Birchview Fund LLC
File 021-235669
$40,813 (est.)$0 (est.)$6,159,354 (est.)
The Investment Manager will receive a management fee based on the issuer's net assets and the Manager may receive an incentive allocation based on the increase in the issuer's net assets.
- no CRD number reported
via Cambridge Investment Research, Inc. (CRD 39543 ↗)
EDGAR ↗
Apr 7, 2022 D
Accelerate Diagnostics, Inc
File 021-440898
$0$0$0None listed on this filingEDGAR ↗
Sep 29, 2021 D/A
Accelerate Diagnostics, Inc
File 021-390838
$0$0$0None listed on this filingEDGAR ↗
Sep 29, 2021 D
Accelerate Diagnostics, Inc
File 021-414960
$0$0$0None listed on this filingEDGAR ↗
Oct 2, 2020 D/A
Monteris BC Holdings 3, LLC
File 021-323191
$0$0$0None listed on this filingEDGAR ↗
Oct 1, 2020 D/A
BIODESIX INC
File 021-356180
$0$0$0None listed on this filingEDGAR ↗
Jun 15, 2020 D/A
Monteris BC Holdings 2, LLC
File 021-287743
$0$0$0None listed on this filingEDGAR ↗
Aug 28, 2019 D
Accelerate Diagnostics, Inc
File 021-347568
$0$0$0None listed on this filingEDGAR ↗
Aug 22, 2019 D
BIODESIX INC
File 021-347197
$0$0$0None listed on this filingEDGAR ↗
Oct 23, 2018 D
BIODESIX INC
File 021-324087
$0$0$0None listed on this filingEDGAR ↗
Jul 18, 2018 D/A
BIODESIX INC
File 021-316987
$0$0$0None listed on this filingEDGAR ↗
May 8, 2018 D
BIODESIX INC
File 021-311910
$0$0$0None listed on this filingEDGAR ↗
Mar 9, 2018 D
BIODESIX INC
File 021-307341
$0$0$0None listed on this filingEDGAR ↗
Apr 24, 2017 D
BIODESIX INC
File 021-285352
$0$0$0None listed on this filingEDGAR ↗
Nov 30, 2016 D
BIODESIX INC
File 021-275359
$0$0$0None listed on this filingEDGAR ↗
Sep 22, 2016 D
ED BC Holdings, LLC
File 021-271106
$0$0$0None listed on this filingEDGAR ↗
Jul 27, 2016 D
BIODESIX INC
File 021-267808
$0$0$0None listed on this filingEDGAR ↗
Feb 12, 2016 D
BIODESIX INC
File 021-257403
$0$0$0None listed on this filingEDGAR ↗
Oct 8, 2015 D
BIODESIX INC
File 021-248973
$0$0$0None listed on this filingEDGAR ↗
Jun 23, 2015 D
BIODESIX INC
File 021-242296
$0$0$0None listed on this filingEDGAR ↗
Jan 13, 2015 D
BIODESIX INC
File 021-232052
$0$0$0None listed on this filingEDGAR ↗
Mar 25, 2014 D
Birchview Fund LLC
File 021-214172
$0$0$0 (est.)
The Investment Manager will receive a management fee based on the issuer's net assets and the General Partner may receive an incentive allocation based on the increase in the issuer's net assets. These amounts cannot be estimated at this time.
None listed on this filingEDGAR ↗
Jan 13, 2014 D/A
BIODESIX INC
File 021-207283
$0$0$0None listed on this filingEDGAR ↗
Oct 22, 2013 D
BIODESIX INC
File 021-205016
$0$0$0None listed on this filingEDGAR ↗
Apr 11, 2013 D
BIODESIX INC
File 021-194883
$0$0$0None listed on this filingEDGAR ↗
Sep 4, 2012 D
BIODESIX INC
File 021-183596
$0$0$0None listed on this filingEDGAR ↗
Jul 17, 2012 D
Accelerate Diagnostics, Inc
File 021-181344
$0$0$0None listed on this filingEDGAR ↗
How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 7

Every issuer that named Matthew Strobeck on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

BS
Pooled Investment Fund · group: Monteris

Birchview SB-68 Healthcare Fund LLC

Burlington, VT · Jun 29, 2026
  • Jun 29, 2026 · D · $0 sold of Indefinite · 0 investors · min. No minimum reported · role: Executive Officer (Managing Member of Birchview SB-68 Healthcare Partners, LLC) EDGAR ↗

No sales reported yet as of the latest filing. Matthew is listed as executive officer.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

BF
Pooled Investment Fund · group: Monteris

Birchview Fund LLC

Burlington, VT · Mar 25, 2014 → Jan 22, 2026 · 13 filings
  • Jan 22, 2026 · D/A · $55,760,701 sold of Indefinite · 53 investors · min. $100,000 · role: Executive Officer, Director, Promoter (Managing Member of Birchview Partners, LLC) EDGAR ↗
  • Jan 22, 2025 · D/A · $50,301,360 sold of Indefinite · 44 investors · min. $100,000 · role: Executive Officer, Director, Promoter (Managing Member of Birchview Partners, LLC) EDGAR ↗
  • Jan 22, 2024 · D/A · $48,951,360 sold of Indefinite · 42 investors · min. $100,000 · role: Executive Officer, Director, Promoter (Managing Member of Birchview Partners, LLC) EDGAR ↗
  • Jan 25, 2023 · D/A · $48,601,360 sold of Indefinite · 41 investors · min. $100,000 · role: Executive Officer, Director, Promoter (Managing Member of Birchview Partners, LLC) EDGAR ↗
  • Jan 24, 2022 · D/A · $48,101,360 sold of Indefinite · 39 investors · min. $100,000 · role: Executive Officer, Director, Promoter (Managing Member of Birchview Partners, LLC.) EDGAR ↗
  • Jan 22, 2021 · D/A · $44,526,360 sold of Indefinite · 34 investors · min. $100,000 · role: Executive Officer, Director, Promoter (Managing Member of Birchview Partners, LLC.) EDGAR ↗
  • Jan 22, 2020 · D/A · $42,626,360 sold of Indefinite · 31 investors · min. $100,000 · role: Executive Officer, Director, Promoter (Managing Member of Birchview Partners, LLC.) EDGAR ↗
  • Jan 11, 2019 · D/A · $42,526,360 sold of Indefinite · 31 investors · min. $1,000,000 · role: Executive Officer, Director, Promoter (Managing Member of Birchview Partners, LLC.) EDGAR ↗
  • Nov 1, 2017 · D/A · $40,476,360 sold of Indefinite · 26 investors · min. $1,000,000 · role: Executive Officer, Director, Promoter (Managing Member of Issuer's Manager) EDGAR ↗
  • Nov 9, 2016 · D/A · $36,926,360 sold of Indefinite · 21 investors · min. $1,000,000 · role: Executive Officer, Director, Promoter (Managing Member of Issuer's Manager) EDGAR ↗
  • Mar 10, 2016 · D/A · $36,926,360 sold of Indefinite · 21 investors · min. $1,000,000 · role: Executive Officer, Director, Promoter (Managing Member of Issuer's Manager) EDGAR ↗
  • Mar 11, 2015 · D · $31,676,360 sold of Indefinite · 16 investors · min. $1,000,000 · role: Executive Officer, Director, Promoter (Managing Member of Issuer's Manager) EDGAR ↗
  • Mar 25, 2014 · D · $20,000,000 sold of Indefinite · 3 investors · min. $1,000,000 · role: Executive Officer, Director, Promoter (Managing Member of Issuer's Manager) EDGAR ↗

Raised $55.8M from 53 investors as of the latest filing. Matthew is listed as executive officer, director, promoter on 13 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

AD
Biotechnology

Accelerate Diagnostics, Inc

Tucson, AZ · Jul 17, 2012 → Apr 7, 2022 · 6 filings
  • Apr 7, 2022 · D · $4,000,000 sold of $4,000,000 · 3 investors · min. No minimum reported · role: Director EDGAR ↗
  • Sep 29, 2021 · D/A · $1,550,000 sold of $1,550,000 · 5 investors · min. No minimum reported · role: Director EDGAR ↗
  • Sep 29, 2021 · D · $30,450,000 sold of $30,450,000 · 3 investors · min. No minimum reported · role: Director EDGAR ↗
  • Mar 1, 2021 · D · $32,000,000 sold of $32,000,000 · 8 investors · min. No minimum reported · role: Director EDGAR ↗
  • Aug 28, 2019 · D · $999,992 sold of $999,992 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 17, 2012 · D · $14,420,000 sold of $14,420,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $32M from 8 investors (100% of the $4M target) as of the latest filing. Matthew is listed as director on 6 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

MB
Investing · group: Monteris

Monteris BC Holdings 3, LLC

Burlington, VT · Oct 10, 2018 → Oct 2, 2020 · 3 filings
  • Oct 2, 2020 · D/A · $6,552,432 sold of Indefinite · 18 investors · min. No minimum reported · role: Executive Officer (Manager of the Issuer.) EDGAR ↗
  • Oct 4, 2019 · D/A · $6,552,432 sold of Indefinite · 18 investors · min. No minimum reported · role: Executive Officer (Manager of the Issuer.) EDGAR ↗
  • Oct 10, 2018 · D · $2,404,958 sold of Indefinite · 17 investors · min. No minimum reported · role: Executive Officer (Manager of the Issuer.) EDGAR ↗

Raised $6.55M from 18 investors as of the latest filing. Matthew is listed as executive officer on 3 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Investing / 506(b) (2,521 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

B
Biotechnology

BIODESIX INC

Boulder, CO · Sep 4, 2012 → Oct 1, 2020 · 20 filings
  • Oct 1, 2020 · D/A · $16,000,000 sold of $31,000,000 · 32 investors · min. No minimum reported · role: Director EDGAR ↗
  • Dec 20, 2019 · D · $3,041,529 sold of $6,000,000 · 27 investors · min. No minimum reported · role: Director EDGAR ↗
  • Aug 22, 2019 · D · $4,902,500 sold of $10,000,000 · 26 investors · min. No minimum reported · role: Director EDGAR ↗
  • Oct 23, 2018 · D · $17,511,736 sold of $27,524,500 · 33 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 18, 2018 · D/A · $7,987,428 sold of $7,987,428 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 16, 2018 · D · $7,987,428 sold of $7,987,428 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 8, 2018 · D · $5,282,162 sold of $10,282,858 · 22 investors · min. No minimum reported · role: Director EDGAR ↗
  • Mar 9, 2018 · D · $1,500,000 sold of $1,500,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 24, 2017 · D · $13,165,482 sold of $25,332,143 · 17 investors · min. No minimum reported · role: Director EDGAR ↗
  • Nov 30, 2016 · D · $5,121,632 sold of $15,700,000 · 12 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 27, 2016 · D · $6,114,729 sold of $7,208,382 · 15 investors · min. No minimum reported · role: Director EDGAR ↗
  • Feb 12, 2016 · D · $17,756,512 sold of $22,202,324 · 24 investors · min. No minimum reported · role: Director EDGAR ↗
  • Oct 8, 2015 · D · $8,609,000 sold of $20,000,000 · 18 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 23, 2015 · D · $10,390,000 sold of $15,148,000 · 24 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jan 13, 2015 · D · $11,285,000 sold of $18,158,000 · 19 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jan 13, 2014 · D/A · $14,407,686 sold of $16,362,306 · 26 investors · min. No minimum reported · role: Director EDGAR ↗
  • Dec 3, 2013 · D · $8,321,790 sold of $9,000,000 · 24 investors · min. No minimum reported · role: Director EDGAR ↗
  • Oct 22, 2013 · D · $4,011,400 sold of $4,011,400 · 21 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 11, 2013 · D · $7,313,440 sold of $14,666,668 · 23 investors · min. No minimum reported · role: Director EDGAR ↗
  • Sep 4, 2012 · D · $5,685,500 sold of $13,400,000 · 11 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $17.8M from 33 investors (57% of the $31M target) as of the latest filing. Matthew is listed as director on 20 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

MB
Investing · group: Monteris

Monteris BC Holdings 2, LLC

Burlington, VT · Jun 13, 2017 → Jun 15, 2020 · 4 filings
  • Jun 15, 2020 · D/A · $4,286,455 sold of $4,286,455 · 18 investors · min. $10,000 · role: Executive Officer (Manager of the Issuer.) EDGAR ↗
  • Jun 12, 2019 · D/A · $4,286,455 sold of $7,529,698 · 17 investors · min. $10,000 · role: Executive Officer (Manager of the Issuer.) EDGAR ↗
  • Jun 12, 2018 · D/A · $4,286,455 sold of $7,529,698 · 17 investors · min. $10,000 · role: Executive Officer (Manager of the Issuer.) EDGAR ↗
  • Jun 13, 2017 · D/A · $4,286,455 sold of $7,529,698 · 17 investors · min. $10,000 · role: Executive Officer (Manager of the Issuer.) EDGAR ↗

Raised $4.29M from 19 investors (100% of the $4.29M target) as of the latest filing. Matthew is listed as executive officer on 4 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Investing / 506(b) (2,521 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

EB
Investing · group: Monteris

ED BC Holdings, LLC

Burlington, VT · Sep 22, 2016
  • Sep 22, 2016 · D · $570,000 sold of $570,000 · 7 investors · min. $5,700 · role: Executive Officer (Manager) EDGAR ↗

Raised $570K from 7 investors (100% of the $570K target) as of the latest filing. Matthew is listed as executive officer.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Investing / 506(b) (2,521 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Other pages with the same name (3)

Separate person records under the same name, not combined with this page. Each line says whether it shares an issuer with this record.

  • Matthew Strobeck — RI, 2 issuers, Mar 8, 2010 → Nov 24, 2010 · no shared issuer
  • Matthew Strobeck — MA, 1 issuer, Sep 8, 2014 → Sep 8, 2014 · no shared issuer
  • Matthew Strobeck — MN, 1 issuer, Nov 21, 2016 → Sep 15, 2022 · no shared issuer

People around Matthew 36

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET.

BC
Management entity

Birchview Capital, LP

Promoter, Executive Officer · 17 shared filings (3 issuers) · also on 6 other issuers

Birchview Capital, LP is on 9 issuers in total — a repeat sponsor. Their page lists every one.

BP
Management entity

Birchview Partners, LLC

Promoter · 13 shared filings (1 issuer)

Listed on the same filings as Matthew Strobeck. Their page shows their other deals.

JS
No photo found yet (own website and image search run after this page is viewed)
Person

Jack Schuler

Director, Executive Officer · 33 shared filings (4 issuers) · also on 9 other issuers

Jack Schuler is on 13 issuers in total — a repeat sponsor. Their page lists every one.

JP
No photo found yet (own website and image search run after this page is viewed)
Person

John Patience

Director · 26 shared filings (2 issuers)

Listed on the same filings as Matthew Strobeck. Their page shows their other deals.

MM
No photo found yet (own website and image search run after this page is viewed)
Person

Mark Miller

Director · 25 shared filings (2 issuers)

Listed on the same filings as Matthew Strobeck. Their page shows their other deals.

RC
No photo found yet (own website and image search run after this page is viewed)
Person

Robert Cawthorn

Director · 20 shared filings (1 issuer)

Listed on the same filings as Matthew Strobeck. Their page shows their other deals.

DB
No photo found yet (own website and image search run after this page is viewed)
Person

David Brunel

Executive Officer, Director · 20 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Matthew Strobeck. Their page shows their other deals.

RC
No photo found yet (own website and image search run after this page is viewed)
Person

Robin Cowie

Executive Officer · 11 shared filings (1 issuer)

Listed on the same filings as Matthew Strobeck. Their page shows their other deals.

FR
No photo found yet (own website and image search run after this page is viewed)
Person

Frank Ronchetti

Executive Officer · 9 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Matthew Strobeck. Their page shows their other deals.

PD
No photo found yet (own website and image search run after this page is viewed)
Person

Paul Beresford, Ph.D.

Executive Officer · 9 shared filings (1 issuer)

Listed on the same filings as Matthew Strobeck. Their page shows their other deals.

GD
No photo found yet (own website and image search run after this page is viewed)
Person

Gary Pestano, Ph.D.

Executive Officer · 9 shared filings (1 issuer)

Listed on the same filings as Matthew Strobeck. Their page shows their other deals.

JP
No photo found yet (own website and image search run after this page is viewed)
Person

Jim Purvis

Executive Officer · 9 shared filings (1 issuer)

Listed on the same filings as Matthew Strobeck. Their page shows their other deals.

BC
No photo found yet (own website and image search run after this page is viewed)
Person

Bobbi Coffin

Executive Officer · 9 shared filings (1 issuer)

Listed on the same filings as Matthew Strobeck. Their page shows their other deals.

LD
No photo found yet (own website and image search run after this page is viewed)
Person

Linda Traylor, Ph.D.

Executive Officer · 9 shared filings (1 issuer)

Listed on the same filings as Matthew Strobeck. Their page shows their other deals.

SH
No photo found yet (own website and image search run after this page is viewed)
Person

Scott Hutton

Executive Officer, Director · 8 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Matthew Strobeck. Their page shows their other deals.

CW
No photo found yet (own website and image search run after this page is viewed)
Person

Charles Watts

Director · 8 shared filings (2 issuers)

Listed on the same filings as Matthew Strobeck. Their page shows their other deals.

HP
No photo found yet (own website and image search run after this page is viewed)
Person

Heinrich Roder, D.Phil.

Executive Officer · 6 shared filings (1 issuer)

Listed on the same filings as Matthew Strobeck. Their page shows their other deals.

FB
No photo found yet (own website and image search run after this page is viewed)
Person

Frank J.M. ten Brink

Director · 5 shared filings (1 issuer)

Listed on the same filings as Matthew Strobeck. Their page shows their other deals.

SR
No photo found yet (own website and image search run after this page is viewed)
Person

Steve Reichling

Executive Officer · 5 shared filings (1 issuer)

Listed on the same filings as Matthew Strobeck. Their page shows their other deals.

TB
No photo found yet (own website and image search run after this page is viewed)
Person

Thomas D. Brown

Director · 5 shared filings (1 issuer)

Listed on the same filings as Matthew Strobeck. Their page shows their other deals.

RP
No photo found yet (own website and image search run after this page is viewed)
Person

Ron Price

Executive Officer, Director · 5 shared filings (1 issuer)

Listed on the same filings as Matthew Strobeck. Their page shows their other deals.

JP
No photo found yet (own website and image search run after this page is viewed)
Person

John J. Phillips

Executive Officer, Director · 5 shared filings (1 issuer)

Listed on the same filings as Matthew Strobeck. Their page shows their other deals.

LF
No photo found yet (own website and image search run after this page is viewed)
Person

Louise L. Francesconi

Director · 4 shared filings (1 issuer)

Listed on the same filings as Matthew Strobeck. Their page shows their other deals.

HM
No photo found yet (own website and image search run after this page is viewed)
Person

Hany Massarany

Director · 4 shared filings (2 issuers)

Listed on the same filings as Matthew Strobeck. Their page shows their other deals.

RG
No photo found yet (own website and image search run after this page is viewed)
Person

Robert Georgantas

Executive Officer · 3 shared filings (1 issuer)

Listed on the same filings as Matthew Strobeck. Their page shows their other deals.

LM
No photo found yet (own website and image search run after this page is viewed)
Person

Lawrence Mehren

Executive Officer, Director · 2 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Matthew Strobeck. Their page shows their other deals.

TG
No photo found yet (own website and image search run after this page is viewed)
Person

Thomas V. Geimer

Director · 1 shared filing (1 issuer)

Listed on the same filings as Matthew Strobeck. Their page shows their other deals.

WS
No photo found yet (own website and image search run after this page is viewed)
Person

William Scully

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Matthew Strobeck. Their page shows their other deals.

WB
No photo found yet (own website and image search run after this page is viewed)
Person

Wendy Blosser

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Matthew Strobeck. Their page shows their other deals.

LF
No photo found yet (own website and image search run after this page is viewed)
Person

Liz Fliegelman

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Matthew Strobeck. Their page shows their other deals.

MS
No photo found yet (own website and image search run after this page is viewed)
Person

Matt Stauffer

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Matthew Strobeck. Their page shows their other deals.

RH
No photo found yet (own website and image search run after this page is viewed)
Person

Romney Humphries

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Matthew Strobeck. Their page shows their other deals.

JF
No photo found yet (own website and image search run after this page is viewed)
Person

Jean Franchi

Director · 1 shared filing (1 issuer)

Listed on the same filings as Matthew Strobeck. Their page shows their other deals.

RD
No photo found yet (own website and image search run after this page is viewed)
Person

Roland Diggelmann

Director · 1 shared filing (1 issuer)

Listed on the same filings as Matthew Strobeck. Their page shows their other deals.

WB
No photo found yet (own website and image search run after this page is viewed)
Person

Wayne C. Burris

Director · 1 shared filing (1 issuer)

Listed on the same filings as Matthew Strobeck. Their page shows their other deals.

The team behind the deals

M
Sponsor group

Monteris

14 issuers · 49 filings · $162.9M reported sold · 2014–2026

One team, 14 deal companies. Matthew Strobeck is listed on 5 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Matthew Strobeck.

Same business address

9 other issuers file from the same address

A shared address can mean the same team, a shared office building or a registered agent. It is a lead, not a conclusion.

Registrations and other filings

Business registration (state registry / Secretary of State)

Individuals are not matched to business registrations — registries list companies, and a name alone is not enough to tie a person to one. Officers and managers appear by name inside each matched company's record on the issuer pages. Registries searched: AL (Alabama Secretary of State — Business Entity Records (arc-sos.state.al.us), searched by issuer name, data as of Oct 24, 2026); CO (Colorado Secretary of State — Business Entities in Colorado (data.colorado.gov), data as of Oct 23, 2026); CT (Connecticut Secretary of the State — Business Registry (data.ct.gov), data as of Oct 24, 2026); FL (Florida Department of State, Division of Corporations — quarterly corporate data file (Sunbiz), data as of Oct 7, 2026); NY (New York Department of State — Corporations and Other Entities (data.ny.gov: All Filings + Active Corporations), data as of Oct 20, 2026); OR (Oregon Secretary of State — Active Businesses, All (data.oregon.gov), data as of Oct 20, 2026); PA (Pennsylvania Department of State — Registered Businesses, Current (data.pa.gov), data as of Oct 6, 2026); TX (Texas Comptroller — Active Franchise Taxpayers incl. Secretary of State file data (data.texas.gov), data as of Oct 24, 2026). Registries of other states have not been searched: many publish no bulk file and require a CAPTCHA or bot challenge on their search page, which we do not bypass (Delaware, for example, offers no public bulk file).

Adviser registration (Form ADV)

A person is never an adviser firm. 3 of the 7 issuers this person is listed on match a Form ADV adviser (searched 24,962 advisers as of Oct 2, 2026): Birchview SB-68 Healthcare Fund LLC, Birchview Fund LLC, Monteris BC Holdings 3, LLC.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to Matthew Strobeck by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 7 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers Matthew Strobeck is listed on: none on file. No website or social profile named in Birchview Fund LLC's SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #44,518 of 374,652 in line (1,386 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (Burlington, VT). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Social and web

LinkedIn people search ↗Instagram ↗X (Twitter) ↗Facebook ↗YouTube ↗Google ↗Google Images ↗Google News ↗Meta Ad Library ↗

Courts

CourtListener / RECAP (federal) ↗PACER case locator (federal, login) ↗Colorado state courts — find the court ↗Vermont state courts — find the court ↗Arizona Judicial Branch public access ↗

Securities regulators

SEC EDGAR full-text search ↗SEC action look-up ↗FINRA BrokerCheck ↗SEC IAPD adviser search ↗

Business registries

Colorado Secretary of State business search ↗Vermont Secretary of State business search ↗Arizona Secretary of State business search ↗OpenCorporates ↗

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Matthew Strobeck appears on a new Form D, or when a court case or SEC action is matched to them. See plans →